Get Your Free Mesothelioma Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Desmoplastic mesothelioma is a rare cell subtype of sarcomatoid malignant mesothelioma. Asbestos exposure is the primary cause. Symptoms include chest pain and fluid buildup in the lungs. Doctors use biopsies to diagnose desmoplastic mesothelioma.
Written by Karen Selby, RN | Medically Reviewed By Dr. Andrea Wolf | Edited By Walter Pacheco | Last Update: December 2, 2024
Desmoplastic mesothelioma is a unique type of the sarcomatoid form of mesothelioma. The term “sarcomatoid” describes cells that are long and spindle-shaped. While this subtype is less common, it is important to understand it, as it can be more serious than other forms of mesothelioma cancer.
This variant is characterized by dense fibrous tissue and fewer cellular features. Unfortunately, it tends to have a poor outlook and can appear in all types of sarcomatoid mesothelioma.
Desmoplastic cells are not easily distinguished and do not show clear patterns. These types of mesothelioma cells create dense nodules of connective tissue in tumors, which can make diagnosis more difficult.
This rare form accounts for about 5% to 10% of all malignant mesothelioma cases. The main cause of this disease is exposure to asbestos, and it can develop in various types of mesothelioma cancer.
When diagnosing mesothelioma, having a sample of tumor tissue, also known as a biopsy, is key. A biopsy helps determine the cell type and the best treatment options.
The fibrous parts of this tumor can sometimes hide variations in the cells, which can lead to misunderstandings in the diagnosis. Occasionally, doctors might mistakenly identify desmoplastic malignant pleural mesothelioma as fibrous pleurisy. Other possible misdiagnoses include pleural fibrosis, rheumatoid disease or spindle cell sarcoma.
Criteria for Diagnosing Desmoplastic Mesothelioma
When desmoplastic mesothelioma spreads, it can sometimes appear less aggressive, making it easy for doctors to mistake the cells for benign fibrous tissue. Imaging scans, like CT or MRI, can be very helpful for pathologists to spot metastasis and correctly diagnose DMM in tough cases.
In 2017, researchers found a protein called GATA-3. This protein helps differentiate desmoplastic mesothelioma from sarcomatoid lung cancer. It is often present in many mesothelioma cases but usually absent in lung carcinoma cases. This discovery supports doctors in staging pleural mesothelioma.
Get Your Free Mesothelioma Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Dense and fibrous areas in the lungs can lead to symptoms similar to pulmonary fibrosis, such as chest pain and fluid buildup. However, it’s important to note that these symptoms do not appear in every case of mesothelioma.
Common Symptoms of Desmoplastic Mesothelioma
The type of tumor cells does not change the symptoms of mesothelioma. For example, patients with pleural mesothelioma often experience shortness of breath, while those with peritoneal mesothelioma may have abdominal pain. If you notice any of these symptoms, it’s important to consult a health care professional for guidance and support.
Most patients don’t know their cell type when I initially speak with them. I help them review their pathology report and explain what sarcomatoid cell types are and what this means for them.
When it comes to treating desmoplastic mesothelioma, there are several options available, including immunotherapy, chemotherapy, and radiation therapy. These treatments work to target cancerous cells, helping to shrink tumors and prevent them from spreading. The choice of treatment often depends on the patient’s age and overall health.
One of the most promising first-line treatments is immunotherapy with nivolumab (Opdivo) and ipilimumab (Yervoy). Following this, chemotherapy with cisplatin and pemetrexed (Alimta) is commonly used.
Radiation therapy can also be beneficial, especially for reducing painful tumors in the chest wall. A recent case study from 2022 highlighted that nivolumab might be particularly effective for patients with sarcomatoid cell types, as these cells often have higher levels of PD-L1 compared to epithelial cells.
It’s important to note that surgery is not typically recommended for this type of mesothelioma because of its high risk of recurrence within a few months. However, there are rare cases where some patients with early-stage or localized tumors have experienced longer survival after surgery.
The main goals of these treatments are to alleviate symptoms, extend survival and enhance the quality of life for patients. For those dealing with fluid buildup in the lungs or abdomen, doctors often suggest procedures like pleurodesis or paracentesis to help manage this issue effectively.
The prognosis for mesothelioma with desmoplasia can be challenging. This subtype is similar to other types of sarcomatoid cancer, making it tricky to diagnose. Many patients find they have advanced disease by the time they receive a diagnosis. Unfortunately, this can lead to a life expectancy of less than one year for those affected.
A comprehensive seven-year study looked at 255 patients with mesothelioma from 1982 to 1989. Researchers discovered 17 cases of the desmoplastic subtype. Among these, 11 were identified as sarcomatoid and six as biphasic, which includes both sarcomatoid and epithelial cell types.
The average survival time from the onset of symptoms to death was about 5.8 months for the sarcomatoid variant and 6.8 months for the biphasic variant. Other studies suggest that the average life expectancy may be around 3.8 months.
While these statistics can feel overwhelming, it is important to seek support and explore treatment options. Every patient’s journey is unique, and there are resources available to help navigate this difficult time.
This Page Contains 12 Cited Articles
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
Selby, K. (2024, December 2). Desmoplastic Mesothelioma. Asbestos.com. Retrieved December 19, 2024, from https://www.asbestos.com/mesothelioma/desmoplastic/
Selby, Karen. "Desmoplastic Mesothelioma." Asbestos.com, 2 Dec 2024, https://www.asbestos.com/mesothelioma/desmoplastic/.
Selby, Karen. "Desmoplastic Mesothelioma." Asbestos.com. Last modified December 2, 2024. https://www.asbestos.com/mesothelioma/desmoplastic/.
A medical doctor who specializes in mesothelioma or cancer treatment reviewed the content on this page to ensure it meets current medical standards and accuracy.
Please read our editorial guidelines to learn more about our content creation and review process.
Dr. Andrea Wolf is the Director of the New York Mesothelioma Program at Mount Sinai in New York City. She focuses on multidisciplinary treatment, clinical research, community outreach and education.
Mesothelioma Center - Vital Services for Cancer Patients & Families doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.